« Previous | Next » | All Messages |  MGEN Message Board Home | recommend post |  Ignore Poster

MGEN News Med Gen Receives Approval for Painenz(R)

BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (OTCBB:MGEN), manufacturers of nationally branded OTC healthier life products, announced that it has received overwhelming approval from the PGA Tour Partners Club for its Painenz® roll on pain relief product.

Painenz® was scrutinized and used by over 350 PGA Tour members for its overall effectiveness in treating pain due to arthritis, muscle strain and general aches due to sports or other activities. The approval rating was better than 67% and the member rating was 6.9. Painenz® was also tested and approved by the Health and Wellness Club, also with excellent results. The December issue of Today’s Health & Wellness magazine has published these excellent results for their readership.

Paul Mitchell, Med Gen’s President in reporting these results indicated that he was going to use the results of these tests in current promotions. “Painenz® is an excellent product for the relief of pain. It is easy to use, not messy and odorless…Best of all, it works and works fast," he said. Med Gen sells this and its other products on its www.medgen.com Online Store.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system, Spray’s the Way (“STW”). It is best known for producing the world’s first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the Un-Diet™ system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems such as its roll-on pain relief formula, Painenz®. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names.

Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol “MGEN”. For information contact Investor Relations 561-750-1100 or www.medgen.com.

This Press Release contains or incorporates by reference “forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.